The ICT Doctoral Training Centre
An exciting new Doctoral Training Centre at the ICT was launched in October 2018. A major investment of £2m by Incanthera Ltd. has enabled a series of new PhD studentships to be created over the next 10 years in the field of anticancer prodrug development, building on recent ICT success in this area. This new funding is made possible following major investment into Incanthera to develop ICT2588, invented at the ICT.
For more information contact Dr Robert Falconer at email@example.com.
Developing anticancer prodrugs
The Centre will enable the training of the next generation of high-calibre cancer scientists, while simultaneously enhancing the support and training of existing PhD students at the ICT. The core theme of new centre will be the development of anticancer prodrugs, which are compounds that remain inactive in the body until they reach their target site, thereby significantly reducing toxicity. This major initiative will provide a pipeline of new intellectual property opportunities for Incanthera in the future. Opportunities for students joining the Centre include a first-class training environment in an Institute with an international reputation for anticancer prodrug development, dedicated research support, a generous research consumables budget, and opportunities to attend a national and international conference.
First fully-funded PhD studentships Announced
The Institue of Cancer Therapeutics Doctoral Training Centre is excited to announce its first three PhD studentships (3.5 years)
Each studentship is fully-funded for 3.5 years. For further information, and how to apply, click on the links above.
Why study with us?
- Fully-funded PhD studentships at a leading UK research institute focused on cancer drug discovery
- Join a multi-disciplinary research environment, with facilities for cancer drug design and synthesis, in vitro pharmacology and molecular biology, and in vivo biology
- Join an academic team with a track record of success in translational research, commercialisation, and delivering drug candidates to the clinic.
What do we offer?
- Doctoral level training in a unique multidisciplinary environment at the interfaces between medicinal chemistry and pharmacology.
- Cutting-edge research projects focused on exciting new anticancer prodrugs.
- Modern facilities.
- Extensive support: an experienced supervisory team, an independent mentor, dedicated medicinal chemistry and pharmacology research support (two active senior laboratory-based researchers working alongside you, and providing training), a strongly-focused team environment.
- Each studentship benefits from a full training package intechniques for compound synthesis, analysis, and for in vitro screening for pharmacology and drug metabolism.
Who should apply, funding and contacts
Applicants with a passion for cancer drug discovery, medicinal chemistry and pharmacology. Candidates should have, or expect to obtain, a first or good upper second class degree (or non-UK equivalent) in a relevant science subject (see individual projects overleaf) or an appropriate Masters qualification. Applications are invited from UK and EU citizens. Outstanding international students may be eligible for a University bursary and will be considered - please enquire.
Studentships cover tuition fees, a tax free stipend (at standard MRC rates) for the duration programme and writing-up (3.5 years total) and a generous research budget. A travel fund is also provided for each student to guarantee participationin a national and international conference. Funding for specific training courses is also included in the Doctoral Training Centre.
For further information or general enquiries about the ICT Doctoral Training Centre, please contact Dr Robert Falconer (firstname.lastname@example.org; Tel +44 (0)1274 235842).